Ameren's Growth Ambitions Face Execution and Regulatory Headwinds

What happened

A recent article from Zacks Investment Research portrays Ameren as poised for growth driven by grid upgrades, renewables, and rising data center demand. The DeepValue report confirms this growth is anchored in a $27.4 billion 2025-29 capital expenditure plan aimed at expanding the rate base. However, the report highlights elevated leverage with net debt to EBITDA at 5.3x and a reliance on approximately $600 million in annual equity issuance, which dilutes per-share earnings growth. Regulatory risks, including tighter allowed returns in Illinois and ESG pressures from coal assets, further complicate the growth trajectory. As a result, the current assessment maintains a 'WAIT' stance, viewing the stock as a fair-valued compounder rather than a compelling buy.

Implication

The positive narrative on rising power demand and investments must be weighed against execution challenges in delivering the capex plan. High leverage and continuous equity dilution may erode per-share earnings despite rate-base expansion, limiting upside. Regulatory outcomes in Missouri and Illinois, such as approvals for MISO transmission projects, are crucial but face uncertainty from evolving policies. ESG-related issues, including coal plant retirements, add cost recovery risks that could impair profitability. Consequently, while Ameren offers stability, current valuations do not provide a margin of safety, warranting a patient approach for better entry points.

Thesis delta

The news article reinforces Ameren's growth drivers but does not alter the DeepValue report's thesis, which already incorporates these elements while emphasizing risks. The report's 'WAIT' recommendation remains unchanged, as valuation and regulatory overhangs persist without new mitigating factors. Investors should continue to monitor for valuation pullbacks or clearer regulatory support before adjusting their stance.